Compare Immunovant Inc. Common Stock (IMVT) vs Keel Infrastructure Corp. Common Stock (KEEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Keel Infrastructure Corp. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.47 (market cap $6.25B), while Keel Infrastructure Corp. Common Stock trades at $3.04 (market cap $1.93B). The key difference: Immunovant Inc. Common Stock is far larger — about 3.2× Keel Infrastructure Corp. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Keel Infrastructure Corp. Common Stock for 1 Days on average.
| IMVT | KEEL | |
|---|---|---|
Market Cap | $6.25B | $1.93B |
Volume | 1,755,411 | 30,868,523 |
Sector | Health | Technology |
52-Week High | $44.96 | $6.66 |
52-Week Low | $17.03 | $1.71 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $2.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →
